×
Home
Current Archive Submission Guidelines
News Contact
Research paper

Effects Of Simvastatin Therapy On Bone Mineral Density In Hypercholesterolemic Postmenopausal Woman

By
Todorka Savić ,
Dimitrije Janković ,
Dimitrije Janković
Irena Janković ,
Irena Janković
Vladmila Bojanić ,
Vladmila Bojanić
Boris Đinđić ,
Boris Đinđić
Nataša Miladinović Tasić ,
Nataša Miladinović Tasić
Ivan Tasić
Ivan Tasić

Abstract

The aim of the study was to evaluate the effects of simvastatin therapy on bone mineral density in hypercholesterolemic postmenopausal women.
Fifty-three women, mean age 62,92  +6,08 years treated at the Institute for Treatment and Rehabilitation Niška Banja were included into this study. All patients were divided into two groups: I group - 32 women with total cholesterol level (Hol≥7,8 
mmol/l) and II control group - 21 women with total cholesterol less than 7,8 mmol/l. Triglycerides (Tg), total cholesterol (Hol), HDL and LDL cholesterol (HDL-C and LDL-C) were determined. Bone mineral density (BMD) was determined on the lumbar spine (LlL4), by “LUNAR DPX” densitometer. The results were expressed as absolute values (g/cm2) and T score. All patients were treated with lifestyle and dietary modification, while patients in group I were treated with 20 mg of simvastat per day. Biochemical markers and bone mineral density were determined at the start and 12 months after.
Simvastatin therapy 20mg⁄day significantly reduced Hol (-12,68%; p<0,01) and LDL-C (-17,99%; p<0,005) levels after 12 months of follow-up. The concentration of TG and HDL-C showed insignificant changes. In II group, there were no significant changes in lipid parameters after 12 months of hypolipemic diet regimen. Increase in BMD +2,81%, (NS) was registered in I group, while decrease in BMD -3,45% (NS) was reported in II group. There was an inverse correlation between BMD changes and LDLC (r=-0,08; p=0,686) in the patients on statin therapy compared to I group (r=0,166, p=0,626). Also, in the same group, an inverse correlation between BMD and Hol (r=0,144; p=0,476) was reported, which was similar to I group (r=-0,125; p=0,715).These results did not reach statistical significance.
Conclusion: Simvastatin therapy showed a positive trend and increase in bone mineral densisty in hypercholesterolemic posmenopausal women after 12 months of follow-up, however, without statistically significant difference. 

References

1.
Pedersen TR, Kjekshus J. Statin drugs and the risk of fracture. 4S Study Group. JAMA. 2000;284:1921–2.

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.